ZOMDF · Zomedica Corp.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-18 | POWERS JOHNNY D |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-12 | POWERS JOHNNY D |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-10 | Klass Russell Kevin |
Sr Vice President, Sales |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-08 | HEATON LARRY C II |
Director, CEO |
Other↑
|
No Securities Owned
|
0 |
| 2026-05-08 | POWERS JOHNNY D |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-11-17 | Cohen Robert |
Director |
Award↑
|
Stock Appreciation Right
|
1,823,107 |
| 2025-11-17 | POWERS JOHNNY D |
Director |
Award↑
|
Stock Appreciation Right
|
1,823,107 |
| 2025-11-17 | Williams Rodney James |
Director |
Award↑
|
Stock Appreciation Right
|
1,975,033 |
| 2025-11-17 | Whelan Sean |
Director |
Award↑
|
Stock Appreciation Right
|
1,975,033 |
| 2025-11-17 | MACLEOD CHRISTOPHER ROSS |
Director |
Award↑
|
Stock Appreciation Right
|
1,823,107 |
| 2025-11-17 | Rowe Jeffrey M |
Director |
Award↑
|
Stock Appreciation Right
|
2,126,959 |
| 2025-11-17 | Nichols Pamela |
Director |
Award↑
|
Stock Appreciation Right
|
1,823,107 |
| 2025-11-13 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
150,000 |
| 2025-11-10 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value.
|
120,000 |
| 2025-11-07 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
5,000 |
| 2025-11-06 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
253,007 |
| 2025-08-12 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
250,000 |
| 2025-08-12 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
745,341 |
| 2025-08-11 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
60,723 |
| 2025-08-11 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
250,000 |
| 2025-08-11 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
250,000 |
| 2025-08-08 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without par value
|
500,000 |
| 2025-06-12 | Klass Russell Kevin |
Sr Vice President, Sales |
Award↑
Filing footnotes — Options to buy Common Stock (Direct)
One quarter (1/4) of the options vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 06/11/2029 |
Options to buy Common Stock
|
500,000 |
| 2025-06-12 | Blair Anthony K |
COO |
Award↑
Filing footnotes — Options to buy Common Stock (Direct)
One quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 06/11/2029. |
Options to buy Common Stock
|
750,000 |
| 2025-06-12 | HEATON LARRY C II |
Director, CEO |
Award↑
Filing footnotes — Options to buy Common Stock (Direct)
one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 6/11/2029 |
Options to buy Common Stock
|
4,000,000 |
| 2025-06-12 | DeHaan-Fullerton Karen |
General Counsel |
Award↑
Filing footnotes — Options to buy Common Stock (Direct)
one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 6/11/2029 |
Options to buy Common Stock
|
500,000 |
| 2025-05-21 | Blair Anthony K |
COO |
Buy↑
|
Common Stock, without par value
|
63,750 |
| 2025-05-21 | Blair Anthony K |
COO |
Buy↑
|
Common Stock, without par value
|
36,250 |
| 2025-05-19 | DeHaan-Fullerton Karen |
General Counsel |
Buy↑
|
Common Stock, without par value
|
104,300 |
| 2025-05-19 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
500,000 |
| 2025-03-17 | Rowe Jeffrey M |
Director |
Buy↑
Filing footnotes — Common Stock, without par value (Indirect)
Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. |
Common Stock, without par value
(I)
|
100,647 |
| 2025-03-17 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
50,000 |
| 2025-03-17 | Rowe Jeffrey M |
Director |
Buy↑
Filing footnotes — Common Stock, without par value (Indirect)
Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. |
Common Stock, without par value
(I)
|
500,000 |
| 2025-03-17 | Jordan Scott |
Chief Business Officer |
Buy↑
|
Common Stock, without par value
|
300,000 |
| 2025-03-17 | Rowe Jeffrey M |
Director |
Buy↑
Filing footnotes — Common Stock, without par value (Indirect)
Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. |
Common Stock, without par value
(I)
|
34,725 |
| 2025-03-17 | Rowe Jeffrey M |
Director |
Buy↑
Filing footnotes — Common Stock, without par value (Indirect)
Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. |
Common Stock, without par value
(I)
|
4,265 |
| 2025-03-17 | Williams Rodney James |
Director |
Buy↑
|
Common Stock, without par value
|
100,000 |
| 2025-03-17 | HEATON LARRY C II |
Director, CEO |
Buy↑
|
Common Stock, without par value
|
10,000 |
| 2025-03-17 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
50,000 |
| 2025-03-17 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
100,000 |
| 2025-03-17 | HEATON LARRY C II |
Director, CEO |
Buy↑
|
Common Stock, without par value
|
118,855 |
| 2025-03-17 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
100,000 |
| 2025-03-17 | MACLEOD CHRISTOPHER ROSS |
Director |
Buy↑
|
Common Stock, without par value
|
143,000 |
| 2025-03-17 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
100,000 |
| 2025-03-17 | HEATON LARRY C II |
Director, CEO |
Buy↑
|
Common Stock, without par value
|
191,817 |
| 2025-03-17 | Klass Russell Kevin |
Sr Vice President, Sales |
Buy↑
|
Common Stock, without $0.070 par value
|
699,980 |
| 2025-03-17 | Williams Rodney James |
Director |
Buy↑
Filing footnotes — Common Stock, without par value (Direct)
A correction is being made to the Form K filed on 3/18/2025 to add shares previously held by Mr. Williams and correct total securities beneficially owned following the transaction |
Common Stock, without par value
|
100,000 |
| 2025-03-17 | POWERS JOHNNY D |
Director |
Buy↑
|
Common Stock, without par value
|
100,000 |
| 2025-03-17 | HEATON LARRY C II |
Director, CEO |
Buy↑
|
Common Stock, without par value
|
179,328 |
| 2025-03-17 | Rowe Jeffrey M |
Director |
Buy↑
Filing footnotes — Common Stock, without par value (Indirect)
Form 4 is being amended to correct the total number of shares held by the Jeffrey M. Rowe Living Trust. The original Form 4 reported that Mr. Rowe held 275,000 shares in his individual capacity, however, these shares are held by the Jeffrey M. Rowe Living Trust. |
Common Stock, without par value
(I)
|
731,368 |